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ReviewAbstract The direct interaction of drugs with the cell membrane is often neglected when drug
effects are studied. Systematic investigations are hindered by the complexity of the natural mem-
brane and model membrane systems can offer a useful alternative. Here some examples are
reviewed of how model membrane architectures including vesicles, Langmuir monolayers and solid
supported membranes can be used to investigate the effects of drug molecules on the membrane
structure, and how these interactions can translate into effects on embedded membrane proteins.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The majority of drugs are designed to target membrane
proteins, since most diseases are related to the malfunction
of these proteins (Yildirim et al., 2007). For example, drugs
have been designed to block channel activities or inhibit pro-
tein binding (Cohen, 2002). Whilst drug–protein interactions
have been systematically studied, the interactions of drugs with
the membrane surrounding the proteins are often neglected.
Membrane proteins require an adequate membrane as a sur-
rounding support to ensure their structural and functionalintegrity. The natural membrane is a complex system,
composed of a wide variety of different constituents such as
lipids, carbohydrates and proteins. The exact membrane com-
position varies from organism to organism, even though there
are some common characteristics for membranes from similar
organisms (Escriba et al., 2008; Dowhan, 1997).
Membrane proteins themselves are in most cases rather
fragile and unstable and typically denature once extracted
from a membrane. Therefore, to fully understand the
functional properties of a membrane protein, it has to be
studied being embedded in a lipid bilayer membrane. The
natural cell membrane, however, is a very complex and highly
diverse system, comprising a large variety of different lipids,
sterols and carbohydrates, yet the composition of the
membrane and its structure play an important role in the
functioning of the embedded membrane proteins. For exam-
ple, changes in the membrane curvature can lead to an opening
or closing of mechanosensitive membrane channels (Perozo
et al., 2002).
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drugs on its structure and function is often neglected in drug
related studies. Similarly, how drug-induced changes of the
membrane properties inﬂuence the function of embedded
membrane proteins is rarely investigated. This is partially
due to the high complexity of the membrane, which renders
systematic investigations very challenging. Additionally,
experiments using whole cells or natural cell membrane
patches are often time- and cost-intensive and mostly not
suitable for routine screening. Finally, non-speciﬁc drug–
membrane interactions, where the drug binds to the mem-
brane, effectively reduce the available free drug, and thus make
the treatment potentially less efﬁcient (McLure et al., 2000;
Nagar and Korzekwa, 2012; Smith et al., 2010). Thus it is clear
that probing the membrane role in drug interactions is critical
to a complete understanding.
Biomimetic model membrane systems offer an alternative
platform to the natural membrane and enable the study of
membrane–drug interactions under very deﬁned and con-
trolled conditions. The underlying structure of any membrane
is a lipid bilayer. Different model systems have been developed
to mimic the fundamental structural and functional properties
of this bilayer. Very prominent examples for model membrane
systems are vesicles or liposomes, Langmuir monolayers, solid
supported bilayers and tethered bilayer lipid membranes. All
of these systems offer certain advantages and disadvantages
for the study of drug–membrane interactions. However, all
of these architectures have been extensively characterised and
analysed using a variety of biophysical techniques. The intrin-
sic properties of these model systems are well studied. No
model system will mimic all properties of a natural membrane,
however, it has been shown that speciﬁc characteristics of a
membrane can be simulated very accurately using model
systems. This offers the possibility for systematic investigation
into membrane-related processes. At the same time it is impor-
tant that the results obtained from model systems are corre-
lated and validated with ﬁndings in natural systems.
Here, some model membrane systems will be introduced
with the speciﬁc emphasis on their use in drug–membrane
interaction studies (see Fig. 1).2. Model membrane systems
Liposomes or vesicles are spherical phospholipid bilayers that
can be formed by extrusion of an aqueous lipid dispersionFigure 1 Schematic of different model membrane architectures: Vesic
are spherical assemblies of lipids (headgroups shown as balls, tails as st
the air/water (blue balls) interface, whilst solid supported membranes a
layer.through a membrane with pores of deﬁned size or by son-
ication of lipid dispersion. Liposomes can be relatively easily
prepared as unilamellar or multilamellar structures. The com-
position of the bilayer can be varied including a wide variety of
different lipids and other membrane components (Peetla et al.,
2009; Chan and Boxer, 2007; Olson et al., 1979).
Whilst vesicles are easily accessible, the number of tech-
niques that can be used limits studies using vesicles. In princi-
ple, two different types of experiments can be performed.
Changes in the shape and size of the vesicles due to an external
stimulus, e.g. the interaction with a drug, can be monitored
using scattering techniques, such as light scattering, small
angle X-ray or neutron scattering. These experiments, how-
ever, do not give any insight into changes in the functionality
of the membrane. Functional properties of the membrane such
as the transport of molecules across the bilayer using vesicles
can be done by ﬂuorescence studies (Domenech et al., 2009).
In such an experiment, a liposome is typically loaded with a
ﬂuorescent dye and for example pore formation in the bilayer
would lead to the efﬂux of the dye and thus a change in the
measured ﬂuorescence.
Multilamellar vesicles were used to investigate the
interaction of the antibacterial compound Rifabutin with
membranes of various compositions (Pinheiro et al., 2013).
Typically, bacterial membranes contain a higher amount of
phosphatidylglycerol headgroups, whereas mammalian cell
membranes are dominated by phosphatidylcholine and phos-
phatidylethanolamine headgroups. In model systems, bacterial
membranes are thus often mimicked by using for examples
dipalmitoylphosphatidylglycerol (DPPG) lipids, whilst
mammalian membranes are represented by dipalmitoylphos-
phatidylcholine (DPPC).
Rifabutin is a wide spectrum antibiotic, which has an intra-
cellular target and thus has to cross the membrane in order to be
active. Analysis of structural changes in the membrane induced
by the presence of the drug can lead to indications about the
mechanism of action. Small and wide angle X-ray diffraction
techniques (SAXS and WAXS) were employed by Pinheiro
et al. to show a preferential interaction of Rifabutin with mem-
branes in the gel phase of a mammalian model system, which
explains the non-toxic effect of the drug. In contrast, the drug
induced pronounced structural changes in a bacterial model
system even though the membrane was in a ﬂuid phase, in good
agreement with in vivo results (Pinheiro et al., 2013).
In another example of the use of liposomes, the effect of
oritavancin, an antibiotic on membrane permeability and lipidles, Langmuir monolayer and solid supported membranes. Vesicles
icks). Floating or Langmuir monolayers are assemblies of lipids at
re lipids bilayers at a solid support, often separated by a thin water
716 J. Knobloch et al.organisation was studied (Domenech et al., 2009). Oritavancin
is a lipoglycopeptide, a new class of antibiotics derived from
glycopeptides that have been synthetically modiﬁed to contain
a lipophilic side chain. Lipoglycopeptides have shown
improved activity against multiple bacterial strains that have
become resistant to glycopeptides. The lipophilic side chain
is thought to induce a novel mechanism of action accounting
for its increased activity possibly via membrane
destabilisation.
Liposomes composed of cardiolipin (CL) and POPG (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol), both
common in bacterial cell membranes but not in mammalian
cellular membranes were studied. Calcein leakage from lipo-
somes was used to measure membrane permeabilisation caused
by oritavancin. It was shown that the level of permeabilisation
was dependent on the lipid composition and hence the physical
properties of the bilayers, speciﬁcally the surface charge, lipid
packing, propensity to induce negative curvature and ﬂuidity.
Liposomes containing CL showed the highest rate and amount
of calcein release, followed by POPC (1-Palmitoyl-2-
oleoylphosphatidylcholine), POPG and then DPPG containing
liposomes.
Liposomes can also be studied by nuclear magnetic reso-
nance (NMR) techniques and circular dichroism. For example,
the interaction of a synthetic antimicrobial peptide, P5, with
liposomes was studied using these two techniques (Fernandez
et al., 2011). P5 was designed based on the structure of two
naturally occurring antimicrobial peptides, cecropin A and
magainin 2, with additional leucine and lysine substitutions
to increase both the hydrophobicity and net charge. This
peptide has been shown to be active against a wide range of
Gram-positive and Gram-negative bacteria as well as to show
anti-fungal and anti-tumour activity whilst not being haemoly-
tic. Both zwitterionic (DMPC, 1,2-dimyristoyl-sn-glycero-3-
phosphocholine) and anionic (DMPG, 1,2-dimyristoyl-
sn-glycero-3-phosphoglycerol) liposomes were used to mimic
the charge of mammalian and bacterial cellular membranes,
respectively. P5 was shown to be unstructured in solution as
well as in the presence of DMPC liposomes using CD. In the
presence of DMPC/DMPG (2:1) liposomes, however, P5
underwent a conformational change to about 40% a-helical
structure.
The order and range of motion of the lipid hydrocarbon
chains were also investigated using 2H NMR. A small increase
in disorder of the hydrocarbon chains close to the head groups
was observed upon addition of P5 to the DMPC liposomes. It
was suggested that P5 perturbed the periphery of the DMPC
liposomes whilst retaining the overall membrane integrity. A
larger disorder of the entire hydrocarbon chain region was
observed upon addition of P5 to the DMPC/DMPG liposomes
indicating the peptide penetrated further into the centre of the
bilayer. 31P NMR also conﬁrmed a signiﬁcant perturbation of
the DMPG containing liposomes after P5 exposure, causing an
increase in the dynamics of the head groups. The selective
interaction of P5 with membranes containing anionic lipids
conﬁrmed the selective activity of P5 against bacterial cells.
Another class of frequently studied drugs are cationic amphi-
philic drugs (CADs). For example, the effect of two CADs,
haloperidol and spiperone on membranes has been investigated
by studying liposomes using various techniques (Baciu et al.,
1847). Small angle X-ray scattering (SAXS), solid state NMR
and ﬂuorescence microscopy (FM) showed rapid partitioningof both CADs into the bilayer, due to their amphiphilic nature,
planarity and relatively small size. Disappearance of the ﬂuid
lamellar phase was observed by SAXS and NMR after
incorporation of the CADs whilst ﬂuorescence and transmission
microscopy showed degradation of giant unilamellar vesicles
(GUVs). Lipid hydrolysis was thought to occur via the tertiary
amine on the CADs (protonated at physiological pH), which
could protonate the ester carbonyl moiety of 1,2-Dioleoyl-sn-
glycero-3-phosphocholine (DOPC) and catalyse ester hydroly-
sis. The products of DOPC ester hydrolysis, a single chain
phospholipid and a fatty acid were observed using magic angle
spinning NMR. Small fragments of the CAD containing GUVs
were seen using FM following GUV degradation. The authors
have postulated that these are micelles formed from the single
chain phospholipids, which retain and transport the CAD to a
neighbouring cellular membrane on either side of the degraded
membrane. The formation of an inverse hexagonal phase result-
ing from the oleic acid enriched membrane was observed after
3 weeks using SAXS and NMR.
Other common model systems are supported bilayer mem-
branes, where a lipid bilayer is placed on a solid support
(Castellana and Cremer, 2006). Such architectures have the
advantage that the solid support offers stability to the bilayer,
making more time-consuming analytical approaches possible.
Also, the solid supports allows for the use of a wide variety
of surface analytical techniques. Typical supports are ‘ﬂat’ sub-
strates such as mica or silicon, (Sackmann, 1996) and gold
electrodes, (Naumann et al., 2003; Vogel et al., 2012) which
allow for additional electrochemical characterisation of the
membrane and possible binding processes at the membrane
interface.
Supported bilayers allow, for example, analysis of the
binding kinetics of a drug using surface plasmon resonance
techniques. This information can give deeper insight into the
interaction mechanism and can lead to the targeted develop-
ment of new drugs with optimised properties. The use of model
systems in general allow more systematic investigations of the
drug–membrane interaction or the screening of certain
parameters, whereas in natural systems, such investigations
are often complicated by a wide variety of components.
Mica and silicon substrates allow for high-resolution imag-
ing of the membrane itself and associated proteins, for example
by using atomic force microscopy (AFM). This has been used
to investigate changes in the nanomechanical properties of the
membrane upon exposure to a drug. For example, it has been
shown that ethanol signiﬁcantly changes membrane properties
such as thickness, Young’s modulus and bending stiffness
(Stetter and Hugel, 2013).
The AFM was also used to probe the inﬂuence of chlorpro-
mazine hydrochloride (CPZ) with supported phospholipid
bilayers (Nussio et al., 2008). Addition of the drug to a pre-
formed DMPC bilayer on a solid support led to changes in
the molecular organisation of the membrane, indicating that
the drug modiﬁes the melting temperature of the phospholipid
as well as the phase behaviour. These results were in good
agreement with SPR data, which also indicated a modiﬁcation
of the melting temperature due to membrane–drug interactions
(Nussio et al., 2007).
Solid supported membranes can also be deposited on con-
ductive substrates, making electrical characterisation of the
membrane possible allowing determination of the resistive
and capacitive characteristics of the membrane. Changes in
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cations about the type of interaction occurring. For example,
electrochemical impedance spectroscopy has been used to
determine how different antimicrobial peptides interact with
a lipid bilayer and allowed for a differentiation between a
pore-forming and a non pore-forming interaction mechanism
(Chang et al., 2008).
Langmuir monolayers are another useful biophysical model
system to study certain aspects of membranes (Junghans et al.,
2010). They are formed by spreading a lipid on an air/water
interface; the packing density of the lipids can then be varied
and the surface pressure is measured. The surface pressure
gives a direct measure of the status of the lipid layer and inter-
actions of drug molecules with this layer can be detected as
changes in the surface pressure. Additionally, visualisation of
the layer is possible, either by optical, ﬂuorescence or
Brewster angle microscopy. Although these monolayers
represent only one half of a bilayer, they can be used to study
biophysical interactions between lipids and drugs (Peetla et al.,
2010; Peetla and Labhasetwar, 2008, 2009).
Langmuir monolayers have the advantage over other model
systems, in that it is comparably much easier to control the
composition and density of the lipid layer. For example, differ-
ent amounts of cholesterol or lipids with different head groups
can be assembled into monolayers. Also, multi-component
mixtures are relatively easy to achieve. Screening experiments
that probe the inﬂuence of different lipids in the membrane
on the effect a drug molecule has on the membrane structure
are therefore easily feasible.
Peetla et al. showed that lipid extracts from drug resistant
and drug sensitive cells showed distinctively different pres-
sure-area isotherms, indicating different biophysical properties
of the membranes. Lipids extracted from membranes resistant
to the anti-cancer drug doxorubicin not only showed much
more rigid phase behaviour than lipids extracted from drug sen-
sitive cells but they also showed much more pronounced inter-
actions with the drug, indicating that the resistance mechanism
is most probably due to the drug interacting with the mem-
brane. In vivo, this would lead to the drug being trapped inside
the lipid bilayer, thus effectively reducing the concentration of
the free drug. Similar results have been obtained for the drug
moxiﬂoxacin, which shows stronger hydrophobic interactions
with Langmuir monolayers than the similar drug ciproﬂoxacin.
In vivo, this corresponds to a higher cellular accumulation of
moxiﬂoxacin (Michot et al., 2005).
Ambike et al. used Langmuir monolayers to probe the
inﬂuence of the membrane composition on drug–membrane
interactions (Ambike et al., 2011). The addition of cholesterol
to a lipid layer enhanced the interactions with the anti-cancer
drug Gemcitabine, which in vivo shows preferential binding to
cholesterol-rich membranes.
The power of model membrane systems can be shown,
when multiple model architectures are used to study drug–
membrane interactions of the same drug. In a comprehensive
study, Nunes et al. have used liposomes, Langmuir monolayers
and solid supported membranes to investigate the inﬂuence of
nonsteroidal anti-inﬂammatory drugs on the structure of a
DPPC membrane (Nunes et al., 2011). Again, the lipid was
chosen to represent the most abundant headgroups in natural
membranes. Using the model systems offers the advantage of
being able to control the pH of the membrane surrounding
medium, thus simulating en environment representingphysiological conditions (pH 7.4) and inﬂamed tissue (pH 5).
By measuring changes in the phase transition temperature in
liposomes due to the presence of a drug, the authors found
indications of a preferential headgroup interaction at pH 7.4
in contrast to interactions with the hydrophobic membrane
core at pH 5. Results from these rather indirect measurements
have been correlated with changes in Langmuir isotherms of
the same lipid due to the presence of the drugs and similar
effects have been observed. Additionally, Langmuir monolay-
ers can also be characterised using complementary techniques
such as ﬂuorescence microscopy, Brewster angle microscopy or
infrared reﬂection-adsorption spectroscopy. The latter tech-
nique has been used to conﬁrm the preferential drug–head-
group interactions at pH 7.4 and the larger change in the
membrane inner structure at pH 5. Finally, changes to the
membrane structure have been visualised in solid supported
membranes using the Atomic Force Microscope. The stronger
effect at pH 5 could also be correlated to the tendency of gas-
tritic toxicity of some of these anti-inﬂammatory drugs.
A special class of membrane proteins are ion channels. They
allow for the selective passage of ions across the lipid bilayer
membrane and malfunction of these proteins is often the cause
for a disease. Functional studies of these proteins are however
difﬁcult, since they require sensitive electronic equipment, such
as a patch-clamp ampliﬁer when investigations are to bemade at
a single molecule level. Patch-clamp experiments using whole
cell are also labour intensive and complicated. Again, model
membrane systems can provide a useful alternative. Ensemble
measurements of protein function can be performed for example
using supported membranes or tethered bilayer membranes
(Ko¨per, 2007; Braunagel et al., 2011). Additionally, planar lipid
bilayer systems or black lipidmembranes (BLM) allow for single
molecule measurements in a controlled environment. Such a
BLM system has been used to investigate the effect of tubulin-
binding chemotherapeutic drugs on the lipid membrane
(Ashrafuzzaman et al., 2012). By combining experimental and
theoretical studies, it has been shown that thiocolchicoside
and taxol can induce pore formation in lipid membranes, which
can add to the cytotoxic effects of these drugs.
3. Summary
The effect of drugs on the structure and function of cell
membranes is an important part of the overall effectiveness
of a drug. These effects can be studied systematically using
model membrane systems. Vesicles, Langmuir monolayer or
solid supported membranes provide the advantage of a system
with reduced complexity, access to a wide variety of character-
isation techniques and control over the individual constituents.
Whilst model membranes will never be able to entirely replace
studies using whole cells, they can provide a useful ﬁrst screen-
ing platform for the investigation of drug–membrane
interactions.
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